USP美國(guó)藥典（2）
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 廣州市自力色譜科儀有限公司
- 品牌 USP/美國(guó)
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 經(jīng)銷(xiāo)商
- 更新時(shí)間 2024/6/13 10:14:57
- 訪問(wèn)次數(shù) 2087
產(chǎn)品標(biāo)簽
聯(lián)系方式：梅經(jīng)理020-38216008 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
氣相色譜儀，液相色譜儀，高效液相色譜柱，Agilent耗材，島津耗材，戴安Dionex產(chǎn)品，HPLC，化學(xué)試劑，標(biāo)準(zhǔn)品，天平，恒溫箱，實(shí)驗(yàn)室設(shè)備
| 供貨周期 | 現(xiàn)貨 |
|---|
| Catalog # | Description |
| 1044470 | Atomoxetine Related Compound A (10 mg) (3-(Methylamino)-1-phenylpropan-1-ol) |
| 1044488 | Atomoxetine Related Compound B (10 mg) (N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine hydrochloride) |
| 1044491 | Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) |
| 1044516 | Atorvastatin Calcium (100 mg) |
| 1044527 | Atorvastatin Related Compound A (20 mg) (Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) |
| 1044538 | Atorvastatin Related Compound B (20 mg) (3S,5R isomer, or (3S,5R)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) |
| 1044549 | Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) |
| 1044550 | Atorvastatin Related Compound D (10 mg) (Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid phenylamide) |
| 1044571 | Atorvastatin Related Compound E (10 mg) (3S, 5S enantiomer of Atorvastatin Calcium) |
| 1044582 | Atorvastatin Related Compound H (20 mg) (5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide) |
| 1044593 | Atorvastatin Related Compound I (20 mg) (tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl)acetate) |
| 1044651 | Atovaquone (200 mg) |
| 1044662 | Atovaquone Related Compound A (25 mg) (cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone) |
| 1044800 | Atracurium Besylate (100 mg) |
| 1044913 | Atomoxetine S-Isomer (10 mg) ((S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride) |
| 1045009 | Atropine Sulfate (500 mg) |
| 1045337 | Avobenzone (500 mg) |
| 1045508 | Aurothioglucose (100 mg) |
| 1045520 | Azacitidine (150 mg) |
| 1045539 | Azacitidine Related Compound A (15 mg) (4-Ami,3,5-triazin-2(1H)-one) |
| 1045541 | Azacitidine Related Compound B (15 mg) (1-O-Acetyl-2,3,5-tri-O-benzoyl-Beta-D-ribofuranose) |
| 1045574 | Azacitidine Related Compound C (15 mg) (1-beta-D-Ribofuranosyl-3-guanylurea picrate) |
| 1045600 | Azaerythromycin A (100 mg) (9-Deoxo-9a-aza-9a-homoerythromycin A) |
| 1045756 | Azaperone (200 mg) |
| 1045803 | Azatadine Maleate (200 mg) |
| 1045938 | Azathioprine Related Compound G (15 mg) (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine) |
| 1045993 | Azathioprine Related Compound A (15 mg) (1-methyl-4-nitro-1H-imidazol-5-amine) |
| 1046001 | Azathioprine (200 mg) |
| 1046012 | Azithromycin Identification Mixture (75 mg) |
| 1046023 | Azithromycin Related Compound H (15 mg) (3'-N-[[4-(acetylamino)phenyl]sulfonyl]-3'-N-demethylazithromycin) |
| 1046045 | Azithromycin Related Compound F (25 mg) (3'-N-demethyl-3'-N-formylazithromycin) |
| 1046056 | Azithromycin (200 mg) |
| 1046067 | Azithromycin Identity (75 mg) |
| 1046078 | Desosaminylazithromycin (15 mg) |
| 1046089 | N-Demethylazithromycin (15 mg) |
| 1046090 | Azithromycin N-Oxide (15 mg) |
| 1046147 | Azo-Aminoglutethimide (100 mg) |
| 1046158 | Azelastine Hydrochloride (300 mg) |
| 1046170 | Azelastine Related Compound B (20 mg) (N'-(1-methylazepan-4-yl)benzohydrazide hydrochloride) |
| 1046191 | Azelastine Related Compound D (20 mg) (4-(4-chlorobenzyl)phthalazin-1(2H)-one) |
| 1046202 | Azelastine Related Compound E (20 mg) (3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one) |
| 1046205 | Aztreonam (200 mg) |
| 1046307 | Aztreonam E-Isomer (15 mg) |
| 1046351 | Azure B (50 mg) (3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride) |
| 1046409 | Open Ring Aztreonam (10 mg) |
| 1047300 | Bacampicillin Hydrochloride (200 mg) |
| 1048007 | Bacitracin Zinc (200 mg) |
| 1048200 | Baclofen (350 mg) |
| 1048222 | Baclofen Related Compound A (50 mg) (4-(4-Chlorophenyl)-2-pyrrolidinone) |
| 1048233 | Bacoside A3 (15 mg) |
| 1048244 | Powdered Bacopa Extract (500 mg) |
| 1048255 | Balsalazide Disodium (200 mg) |
| 1048266 | Balsalazide Related Compound A (100 mg) ((E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt) |
| 1048277 | Balsalazide Related Compound B (25 mg) ((E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid) |
| 1048288 | Beta Glucan (1 g) (Beta Glucan from Baker's Yeast (Saccharomyces cerevisiae) |
| 1048415 | Lagerstroemia speciosa Leaf Dry Extract (1g) |
| 1048506 | Beclomethasone Dipropionate (200 mg) |
| 1048550 | Behenoyl Polyoxylglycerides (500 mg) |
| 1048572 | Bemotrizinol (200 mg) |
| 1048583 | Bemotrizinol Impurity Mixture (100 mg) |
| 1048619 | Benazepril Hydrochloride (125 mg) |
| 1048620 | Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) |
| 1048630 | Benazepril Related Compound B (15 mg) ((3S)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) |
| 1048641 | Benazepril Related Compound C (50 mg) ((3S)-3-[[(1S)-1-carboxy-3-phenylpropyl]amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine]-1-acetic acid) |
| 1048652 | Benazepril Related Compound D (15 mg) (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride) |
| 1048663 | Benazepril Related Compound E (25 mg) (3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride) |
| 1048674 | Benazepril Related Compound F (15 mg) (tert-butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate) |
| 1048685 | Benazepril Related Compound G (15 mg) (COLD SHIPMENT REQUIRED) ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic acid, ethyl ester) |
| 1049000 | Bendroflumethiazide (200 mg) |
| 1050009 | Benoxinate Hydrochloride (200 mg) |
| 1050905 | Benzaldehyde (3 X 1 mL) (List Chemical) |
| 1050949 | Benzaldehyde Propylene Glycol Acetal (5 x 0.5 mL) |
| 1050982 | Benzalkonium Bromide (C12) (150 mg) |
| 1051001 | Benzalkonium Chloride (5 mL of approx. 10% aqueous solution) |
| 1051500 | Benzethonium Chloride (500 mg) |
| 1051602 | Benzhydrol (50 mg) |
| 1054000 | Benzocaine (500 mg) |
| 1055002 | Benzoic Acid (300 mg) |
| 1056005 | Benzonatate (1 g) |
| 1056130 | Benzophenone (25 mg) (Diphenylmethanone) |
| 1056504 | 1,4-Benzoquinone (200 mg) |
| 1057507 | Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) |
| 1059003 | Benzphetamine Hydrochloride CIII (200 mg) |
| 1061005 | Benztropine Mesylate (200 mg) |
| 1061901 | Benzyl Alcohol (500 mg/ampule) |
| 1062008 | Benzyl Benzoate (5 g) |
| 1062020 | Benzyl Disulfide (200 mg) |
| 1062074 | Benzyl Mercaptan (5 x 0.5 mL) |
| 1062085 | Benzyl Methyl Sulfide (5 x 0.5 mL) |
| 1064003 | 1-Benzyl-3-methyl-5-aminopyrazole Hydrochloride (25 mg) |
| 1064058 | 3-Benzyl-4-Heptanone (5 x 0.5 mL) |
| 1064122 | N-Benzyl-N-methyl-ethanolamine (3 x 0.2 mL) (2-[benzyl(methyl)amino]ethanol) |
| 1065006 | Bephenium Hydroxynaphthoate (500 mg) |
| 1065210 | Berberine Chloride (50 mg) |
| 1065480 | Beta Carotene (7 x 100 mg) (COLD SHIPMENT REQUIRED) |
| 1065491 | Beta Carotene System Suitability (200 mg) (COLD SHIPMENT REQUIRED) |
| 1065550 | Betadex Sulfobutyl Ether Sodium (500 mg) |
| 1065618 | Betahistine Hydrochloride (200 mg) |
| 1065695 | Betaine (1 g) |
| 1065709 | Betaine Hydrochloride (200 mg) |
| 1066009 | Betamethasone (200 mg) |
| 1067001 | Betamethasone Acetate (500 mg) |
| 1067307 | Betamethasone Benzoate (200 mg) |
| 1067704 | Betamethasone Dipropionate (125 mg) |
| 1068004 | Betamethasone Sodium Phosphate (500 mg) |
| 1069007 | Betamethasone Valerate (200 mg) |
| 1069018 | Betamethasone Valerate Related Compound A (50 mg) (9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-21-yl valerate) |
| 1069903 | Betaxolol Hydrochloride (200 mg) |
| 1070006 | Betazole Hydrochloride (200 mg) |
| 1071009 | Bethanechol Chloride (200 mg) |
| 1071202 | Bicalutamide (200 mg) |
| 1071213 | Bicalutamide Related Compound A (25 mg) (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-prop*) |
| 1071224 | Bicalutamide Related Compound B (10 mg) ((RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylprop*) |
| 1071268 | Powdered Bilberry Extract (500 mg) |
| 1071304 | Bile Salts (10 g) |
| 1071381 | Biochanin A (20 mg) |
| 1071508 | Biotin (200 mg) |
| 1072001 | Biperiden (200 mg) |
| 1073004 | Biperiden Hydrochloride (200 mg) |
| 1073423 | Biphenyl (500 mg) |
| 1074007 | Bisacodyl (125 mg) |
| 1074030 | Bisacodyl Related Compound A (20 mg) (4,4'-(Pyridin-2-ylmethylene)diphenol) |
| 1074042 | Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) |
| 1074051 | Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
| 1074073 | Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
| 1074700 | 2,5-Bis(D-arabi,2,3,4-tetrahydroxybutyl)pyrazine (25 mg) |
| 1075203 | Bis(2-ethylhexyl)maleate (2 g) (Maleic acid, bis(2-ethylhexyl)ester) |
| 1075305 | Bisdesmethoxycurcumin (30 mg) |
| 1075509 | p-Bis(di-n-propyl)carbamylbenzenesulfonamide (50 mg) |
| 1075531 | Bismuth Citrate (100 mg) |
| 1075553 | Bismuth Subsalicylate (100 mg) |
| 1075600 | Bismuth Subcarbonate (1 g) (AS) |
| 1075622 | Bismuth Subgallate (2 g) (AS) |
| 1075644 | Bismuth Subnitrate (1.5 g) (AS) |
| 1075677 | Bisoctrizole (200 mg) |
| 1075688 | Bisoctrizole Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol) |
| 1075699 | Bisoctrizole Resolution Mixture (50 mg) |
| 1075757 | Bisoprolol Fumarate (200 mg) |
| 1076057 | Borage Seed Oil (1 g) |
| 1076115 | Bosentan (200 mg) |
| 1076126 | Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide) |
| 1076137 | Bosentan Related Compound B (15 mg) (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide) |
| 1076148 | Bosentan Related Compound C (15 mg) (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane) |
| 1076159 | Bosentan Related Compound D (15 mg) (4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine) |
| 1076160 | Bosentan Related Compound E (15 mg) (4-(tert-butyl)benzenesulfonamide) |
| 1076192 | BSA for Protein Quantitation (5 x 1 mL) |
| 1076206 | Powdered Black Cohosh Extract (1.5 g) |
| 1076250 | Boswellia Serrata Extract (1 g) |
| 1076261 | 3-Acetyl-11-Keto-Beta-Boswellic Acid (20 mg) |
| 1076308 | Bleomycin Sulfate (15 mg) |
| 1076341 | Boric Acid (1 g) |
| 1076352 | Bretylium Tosylate (200 mg) |
| 1076363 | Brinzolamide (200 mg) |
| 1076374 | Brinzolamide Related Compound A (50 mg) ((S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide) |
| 1076385 | Brinzolamide Related Compound B (50 mg) ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate) |
| 1076419 | Brimonidine Related Compound A (50 mg) (5-Bromoquinoxalin-6-amine) |
| 1076421 | Brimonidine Related Compound B (50 mg) (1-(5-Bromoquinoxalin-6-yl)thiourea) |
| 1076465 | Bromazepam CIV (100 mg) (AS) |
| 1076501 | Bromocriptine Mesylate (150 mg) |
| 1077005 | Bromodiphenhydramine Hydrochloride (200 mg) |
| 1077708 | 8-Bromotheophylline (400 mg) |
| 1077887 | Bromperidol Decanoate (15 mg) |
| 1078008 | Brompheniramine Maleate (125 mg) |
| 1078201 | Budesonide (200 mg) |
| 1078245 | Budesonide Related Compound E (25 mg) (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) |
| 1078267 | Budesonide Related Compound G (25 mg) (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) |
| 1078289 | Budesonide Related Compound L (25 mg) (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) |
| 1078303 | Bumetanide (125 mg) |
| 1078325 | Bumetanide Related Compound A (10 mg) (3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid) |
| 1078336 | Bumetanide Related Compound B (25 mg) (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid) |
| 1078507 | Bupivacaine Hydrochloride (300 mg) |
| 1078518 | Bupivacaine Related Compound A (50 mg) (6-(butylamino)-N-(2,6-dimethylphenyl)hex*) (AS) |
| 1078529 | Bupivacaine Related Compound B (50 mg) (N-(2,6-dimethylphenyl)piperidine-2-carboxamide) |
| 1078573 | Buspirone Related Compound A (75 mg x 2) (2-(Piperazin-1-yl)pyrimidine) |
| 1078642 | Buspirone Related Compound K (50 mg) (8-azaspiro[4.5]decane-7,9-dione) |
| 1078700 | Buprenorphine Hydrochloride CIII (50 mg) |
| 1078711 | Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol) |
| 1078722 | Buprenorphine System Suitability Mixture CII (50 mg) (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine) |
| 1078733 | Bupropion Hydrochloride (200 mg) |
| 1078744 | Bupropion Hydrochloride Related Compound A (15 mg) (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride) |
| 1078755 | Bupropion Hydrochloride Related Compound B (10 mg) (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride) |
| 1078766 | Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)-2-hydroxypropan-1-one) (COLD SHIPMENT REQUIRED) |
| 1078799 | Bupropion Hydrochloride Related Compound F (40 mg) (1-(3-chlorophenyl)-1-hydroxy-2-propanone) (COLD SHIPMENT REQUIRED) |
| 1078802 | Buspirone Hydrochloride (200 mg) |
| 1078813 | Buspirone Related Compound G (50 mg) (1,4-Di(pyrimidin-2-yl)piperazine) |
| 1078824 | Buspirone Related Compound L (75 mg x 2) (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione) |
| 1078835 | Buspirone Related Compound N (50 mg) (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione) |
| 1078846 | Bupropion Hydrobromide (200 mg) |
| 1079000 | Butabarbital CIII (200 mg) |
| 1080000 | Butacaine Sulfate (600 mg) |
| 1081002 | Butalbital CIII (200 mg) |
| 1081501 | Butamben (200 mg) |
| 1081807 | 1-Butanol (1.2 mL/ampule; 3 ampules) |
| 1081829 | 2-Butanol (1.2 mL/ampule; 3 ampules) |
| 1081842 | 2,3-Butanedithiol (3 x 1 g) |
| 1082300 | Butoconazole Nitrate (200 mg) |
| 1082504 | Butorphanol Tartrate CIV (350 mg) |
| 1082592 | Butyl Anthranilate (1 mL) (List Chemical) |
| 1082606 | Butyl Acetate (1.2 mL/ampule; 3 ampules) |
| 1082617 | Butyl Cinnamate (500 mg) |
| 1082628 | Butyl Heptanoate (5 x 0.5 mL) |
| 1082639 | Butyl Stearate (500 mg) |
| 1082640 | Butyl Isothiocyanate (1 mL) |
| 1082672 | Butyl Valerate (1 ml) |
| 1082708 | Butylated Hydroxytoluene (500 mg) |
| 1082901 | Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (25 mg) |
| 1082956 | Butane-1,3-diol (1 mL) |
| 1082967 | Butyl Hexanoate (3 x 500 mg) |
| 1083008 | 2-tert-Butyl-4-hydroxyanisole (200 mg) |
| 1083100 | 3-tert-Butyl-4-hydroxyanisole (200 mg) |
| 1083303 | tert-Butylmethyl ether (1.2 mL/ampule; 3 ampules) |
| 1083529 | Butyl Palmitate (500 mg) |
| 1084000 | Butylparaben (200 mg) |
| 1084215 | Allyl Butyrate (5 x 0.5 mL) |
| 1084259 | Butyraldehyde (3 x 1.2 mL) |
| 1084292 | CD34+ Cell Enumeration System Suitability (1.24 x 10^4 CD34+ Cells) |
| 1084306 | Cabergoline (125 mg) |
| 1084995 | Caffeic Acid (15 mg) |
| 1085003 | Caffeine (200 mg) |
| 1086006 | Caffeine Melting Point Standard (1 g) (Approximay 236 degrees) |
| 1086039 | Caftaric Acid (20 mg) |
| 1086108 | Calcifediol (75 mg) |
| 1086141 | Calcipotriene (200 mg) |
| 1086152 | Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol) |
| 1086200 | Calcitonin Salmon (20 mg) (COLD SHIPMENT REQUIRED) |
| 1086210 | Calcitonin Salmon Related Compound A (20 mg) (N-acetyl-Cys(1)-calcitonin salmon) (COLD SHIPMENT REQUIRED) |
| 1086221 | Calcitonin Salmon Related Compound B (0.34 mg) (calcitonin salmon-glycine) (COLD SHIPMENT REQUIRED) |
| 1086301 | Calcitriol (10 mg) (COLD SHIPMENT REQUIRED) |
| 1086312 | Calcitriol Solution (5 mL) (COLD SHIPMENT REQUIRED) |
| 1086334 | Calcium Acetate (1 g) (AS) |
| 1086356 | Calcium Ascorbate (200 mg) |
| 1086378 | Calcium Benzoate (200 mg) |
| 1086403 | Calcium Carbonate (1 g) |
| 1086436 | Calcium Chloride (1 g) (AS) |
| 1086447 | Calcium Cyclamate (200 mg) |
| 1086800 | Calcium Gluceptate (200 mg) |
| 1086822 | Calcium Gluconate Anhydrous (200 mg) |
| 1086833 | Calcium Gluconate Monohydrate (200 mg) |
| 1086855 | Calcium Hydroxide (1 g) (AS) |
| 1086866 | Calcium (-)-Hydroxycitrate (150 mg) |
| 1086888 | Calcium Lactate (1 g) |
| 1086902 | Calcium Lactobionate (200 mg) |
| 1086935 | Calcium Levulinate (1 g) (AS) |
| 1086957 | Calcium Lignosulfonate (40-65) (2 g) |
| 1087009 | Calcium Pantothenate (200 mg) (Vitamin B5) |
| 1087031 | Tribasic Calcium Phosphate (1 g) (AS) |
| 1087202 | Calcium Saccharate (200 mg) |
| 1087359 | Calcium Stearate (2 g) (AS) |
| 1087360 | Calcium Succinate (200 mg) |
| 1087406 | Calcium Sulfate (1 g) (AS) |
| 1087472 | Calycosin (50 mg) (7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one) |
| 1087483 | Calycosin 7-O-beta-D-Glucopyranoside (50 mg) (3-(3-Hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside) |
| 1087508 | Camphor (1 g) |
| 1087520 | D-camphor sulfonic acid (100 mg) |
| 1087701 | Candelilla Wax (250 mg) |
| 1087803 | Candesartan Cilexetil (100 mg) |
| 1087814 | Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) |
| 1087825 | Candesartan Cilexetil Related Compound B (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 1-{[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydrobenzimidazole-7-carboxylate) |
| 1087847 | Candesartan Cilexetil Related Compound D (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate) |
| 1087869 | Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate) |
| 1087870 | Candesartan Cilexetil Related Compound G (10 mg) (1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid) |
| 1090014 | Exo-tetrahydrocannabinol (1 mL) |
| 1090150 | Canola Oil (1 g) |
| 1090706 | Capecitabine (200 mg) |
| 1090717 | Capecitabine Related Compound A (10 mg) (5'-deoxy-5-fluorocytidine) |
| 1090728 | Capecitabine Related Compound B (20 mg) (5'-deoxy-5-fluorouridine) |
| 1090739 | Capecitabine Related Compound C (10 mg) (2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine) (COLD SHIPMENT REQUIRED) |
| 1091006 | Capreomycin Sulfate (250 mg) |
| 1091028 | Capric Alcohol (5 x 30 mg) |
| 1091040 | Caprylic Acid (300 mg) |
| 1091108 | Capsaicin (100 mg) |
| 1091200 | Captopril (200 mg) |
| 1091221 | Captopril Disulfide (100 mg) |
| 1091505 | Caprylocaproyl Polyoxylglycerides (200 mg) |
| 1092009 | Carbachol (200 mg) |
| 1093001 | Carbamazepine (100 mg) |
| 1093012 | Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarbamazepine) |
| 1093023 | Carbamazepine Related Compound B (50 mg) (Iminostilbene) |
| 1093205 | Carbarsone (200 mg) |
| 1093500 | Carbenicillin Indanyl Sodium (300 mg) |
| 1094004 | Carbenicillin Monosodium Monohydrate (200 mg) |
| 1095506 | Carbidopa (400 mg) |
| 1095517 | Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidopa) |
| 1096000 | Carbinoxamine Maleate (200 mg) |
| 1096019 | Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanone) |
| 1096021 | Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanol) |
| 1096032 | Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate) |
| 1096407 | Carboplatin (100 mg) |
| 1096509 | Carboprost Tromethamine (30 mg) |
| 1096510 | Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid) |
| 1096529 | Carglumic Acid Related Compound B (30 mg) ((S)-2,7-dioxo-1,3-diazepane-4-carboxylic acid) |
| 1096531 | Carboxymethylcellulose Calcium (1.5 g) (AS) |
| 1096553 | Carboxymethylcellulose Sodium (1.5 g) |
| 1096564 | D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glutamic acid) |
| 1096586 | Carglumic Acid (200 mg) |
| 1096597 | Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2-methylpentyl carbamate) |
| 1096600 | Carisoprodol CIV (1 g) |
| 1096611 | Carmellose (500 mg) |
| 1096622 | Carvedilol (200 mg) |
| 1096633 | Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol) |
相關(guān)分類(lèi)
該廠商的其他產(chǎn)品
相關(guān)技術(shù)文章
- 標(biāo)準(zhǔn)物質(zhì)你不知道的哪些應(yīng)用
- 標(biāo)準(zhǔn)物質(zhì)管理不符合項(xiàng)怎么整改
- ATCC 在中國(guó)市場(chǎng)的銷(xiāo)量分析
- 谷氨酸發(fā)酵罐雜菌污染的原因與危
- 醫(yī)療器械設(shè)備關(guān)系人民的生命健康
- 綠色農(nóng)產(chǎn)品和有機(jī)農(nóng)產(chǎn)品所涉及的
- 無(wú)機(jī)混標(biāo)溶液是一種由兩種或更多
- 不等RIA反應(yīng)達(dá)到動(dòng)態(tài)平衡就終止
- 細(xì)胞膜上能增強(qiáng)C3b對(duì)H因子親和力
- 超導(dǎo)研究基本可以分為四個(gè)大方向
采購(gòu)中心
化工儀器網(wǎng)